Browse By Publication: Cancer Research
|Up a level|
Number of items: 58.
Azzam, Hala S. & Thompson, Erik W. (1992) Collagen-induced activation of the Mr. 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Research, 52(16), pp. 4540-4544.
Bauskin, Asne, Brown, David, Junankar, Simon, Rasiah, Krishan, Eggleton, Sarah, Hunter, Mark, et al. (2005) The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome. Cancer Research, 65(6), pp. 2330-2336.
Bourcy, Morgane, Suarez-Carmona, Meggy, Lambert, Justine, Francart, Marie-Emilie, Schroeder, Hélène, Delierneux, Céline, et al. (2016) Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells. Cancer Research, 76(14), pp. 4270-4282.
Brünner, Nils, Frandsen, Thomas L., Holst-Hansen, Claus, Bei, Mian, Thompson, Erik W., Wakeling, Alan E., et al. (1993) MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Research, 53(14), pp. 3229-3232.
Buchanan, Grant, Birrell, Stephen N., Peters, Amelia A., Bianco-Miotto, Tina, Ramsay, Katrina, Cops, Elisa J., et al. (2005) Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate. Cancer Research, 65(18), pp. 8487-8496.
Buchanan, Grant, Ricciardelli, Carmella, Harris, Jonathan, Prescott, Jennifer, Yu, Chiao, Butler, Lisa, et al. (2007) Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine-rich Tetratricopeptide Repeat Containing Protein Alpha. Cancer Research, 67, pp. 10087-10096.
Byron, Sara, Gartside, Michael, Wellens, Candice, Mallon, Mary, Keenan, Jack, Powell, Matthew, et al. (2008) Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Research, 68(17), pp. 6902-6907.
Castellano, Marina, Pollock, Pamela M., Walters, Marilyn K., Sparrow, Louise E., Down, Louise M., Gabrielli, Brian G., et al. (1997) CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Research, 57(21), pp. 4868-4875.
Chaffer, C.L., Brennan, J.P., Slavin, J.L., Blick, T., Thompson, E.W., & Williams, E.D. (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis : role of fibroblast growth factor receptor-2. Cancer Research, 66(23), pp. 11271-11278.
Cheung, Hiu Wing, Chun, Abel, Wang, Qi, Deng, Wen, Hu, Liang, Guan, Xin Yuan, et al. (2006) Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Research, 66(8), pp. 4357-4367.
Cheung, Hiu Wing, Jin, Dong-Yan, Ling, Patrick, Wong, Yong Chuan, Wang, Qi, Tsao, Sai Wah, et al. (2005) Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Research, 65(4), pp. 1450-1458.
Conway, Kathleen, Edmiston, Sharon N., Cui, Lisa, Drouin, S. Scott, Pang, Jingzhong, He, Mei, et al. (2002) Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Research, 62(7), pp. 1987-1995.
Djakiew, D., Pflug, B.R., Delsite, R., Onoda, M., Lynch, J.H., Arand, G., et al. (1993) Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Research, 53(6), pp. 1416-1420.
Dong, Ying, Tan, Olivia, Loessner, Daniela, Stephens, Carson, Walpole, Carina, Boyle, Glen, et al. (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha 5 beta1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Research, 70(7), pp. 2624-2636.
Dry, Jonathan R., Pavey, Sandra, Pratilas, Christine A., Harbron, Chris, Runswick, Sarah, Hodgson, Darren, et al. (2010) Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244). Cancer Research, 70(6), pp. 2264-2273.
Ettinger, Susan, Sobel, Richard, Whitmore, Tanis G., Akbari, Majid, Bradley, Dawn R., Gleave, Martin, et al. (2004) Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Research, 64(6), pp. 2212-2221.
Gilles, C., Bassuk, J.A., Pulyaeva, H., Sage, E.H., Foidart, J.M., & Thompson, E.W. (1998) SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Research, 58(23), pp. 5529-5536.
Hacker, Elke, Muller, H. Konrad, Irwin, Nicole, Gabrielli, Brian, Lincoln, Doug, Pavey, Sandra, et al. (2006) Spontaneous and UVR-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Research, 66(6), pp. 2946-2952.
Hollier, Brett G., Tinnirello, Agata A., Werden, Steven J., Evans, Kurt W., Taube, Joseph H., Sarkar, Tapasree Roy, et al. (2013) FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Research, 73, pp. 1981-1992.
Hooper, John D., Nicol, David L., Dickinson, Joanne L., Eyre, Helen J., Scarman, Anthony L., Normyle, John F., et al. (1999) Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Research, 59(13), pp. 3199-3205.
Kammerer, Stefan, Roth, Richard B., Reneland, Richard, Marnellos, George, Hoyal, Carolyn R., Markward, Nathan J., et al. (2004) Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Research, 64(24), pp. 8906-8910.
Ko, Yon, Abel, Josef, Harth, Volker, Bröde, Peter, Antony, Christiane, Donat, Susanne, et al. (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Research, 61(11), pp. 4398-4404.
Kwok, Wai Kei, Ling, Patrick, Lee, Tak-Wing, Lau, Tracy, Zhou, Chun, Zhang, Xiao-Meng, et al. (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Research, 65(12), pp. 5153-5162.
Locke, Jennifer, Guns, Emma, Lubik, Amy, Adomat, Hans, Hendy, Stephen, Wood, Catherine, et al. (2008) Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Research, 68(15), pp. 6407-6415.
Lubik, Amy, Gunter, Jennifer, Hendy, Stephen, Locke, Jennifer, Adomat, Hans, Thompson, Vanessa, et al. (2011) Insulin increases De Novo Steroidogenesis in prostate cancer cells. Cancer Research, 71(17), pp. 5754-5764.
Ma, Stephanie, Chan, Yuen Piu, Kwan, Pak Shing, Lee, Terence, Yan, Mingxia, Tang, Kwan Ho, et al. (2011) MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Research, 71(2), pp. 583-592.
Morris, Christelle, Tomimatsu, Nozomi , Richard, Derek J., Cluet, David, Burma, Sandeep, Khanna, Kum Kum , et al. (2012) INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells. Cancer Research, 72(8), pp. 2006-2016.
Mostaghel, Elahe, Nelson, Peter S., Nelson, Colleen, & Montgomery, R. Bruce (2010) Intraprostatic steroidogenic enzymes - letter. Cancer Research, 70(20), pp. 8247-8249.
Mostaghel, Elahe, Page, Stephanie, Lin, Daniel, Fazli, Ladan, Coleman, Ilsa, True, Lawrence, et al. (2007) Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer. Cancer Research, 67(10), pp. 5033-5041.
Nishida, Y., Miyamori, H., Thompson, E.W., Takino, T., Endo, Y., & Sato, H. (2008) Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for ProMMP-2 generates active MMP-2. Cancer Research, 68(21), pp. 9096-9104.
Pereira, J.J., Meyer, T., Docherty, S.E., Reid, H.H., Marshall, J., Thompson, E.W., et al. (2004) Bimolecular interaction of Insulin-Like Growth Factor (IGF) binding protein-2 with αvβ3 negatively modulates IGF-I-Mediated migration and tumor growth. Cancer Research, 64(3), pp. 977-984.
Peters, Amelia, Buchanan, Grant, Ricciardelli, Bianco-Miotto, Tina, Centenera, Harris, Jonathan, et al. (2009) Androgen receptor inhibits estrogen receptor-A activity and is prognostic in breast cancer. Cancer Research, 69(15), pp. 6131-6140.
Petricoin III, Emanuel F., Espina, Virginia, Araujo, Robyn P., Midura, Brieanne, Yeung, Choh, Wan, Xiaolin, et al. (2007) Phosphoprotein pathway mapping: Akt/Mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Research, 67(7), pp. 3431-3440.
Pinnix, Chelsea, Lee, John, Liu, Zhao-Jun, McDaid, Ronan, Balint, Klara, Beverly, Levi, et al. (2009) Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Research, 69(13), pp. 5312-5320.
Pollock, Pamela M., Welch, John, & Hayward, Nicholas K. (2001) Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Research, 61, pp. 1154-1161.
Price, J.T., Quinn, J.M.W., Sims, N.A., Vieusseux, J., Waldeck, K., Docherty, S.E., et al. (2005) The heat shock protein 90 inhibitor, 17-allylamino-17- demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Research, 65(11), pp. 4929-4938.
Price, J.T., Tiganis, T., Agarwal, A., Djakiew, D., & Thompson, E.W. (1999) Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. Cancer Research, 59(21), pp. 5475-5478.
Qin, Jian-Zhong, Ziffra, Jeffrey, Stennett, Lawrence, Bodner, Barbara, Bonish, Brian, Chaturvedi, Vijaya, et al. (2005) Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Research, 65(14), pp. 6282-6293.
Reich, R., Thompson, E.W., Iwamoto, Y., Martin, G.R., Deason, J.R., Fuller, G.C., et al. (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Research, 48(12), pp. 3307-3312.
Rocchi, Palma, Beraldi, Eliana, Ettinger, Susan, Fazli, Ladan, Vessella, Robert, Nelson, Colleen, et al. (2005) Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Research, 65(23), pp. 11083-11093.
Russell, Pamela J., Soekmadji, Carolina, Thierry, Benjamin, Cowin, Gary, Strait-Gardner, T., Verma, N., et al. (2013) Use of targeted magnetic nanoparticles for imaging in prostate cancer. In AACR Special Conference on Advances in Prostate Cancer Research, 6-9 February 2012, Orlando, FL.
Savage, Kienan I., Matchett, Kyle B., Barros, Eliana M., Cooper, Kevin M., Irwin, Gareth W., Gorski, Julia J., et al. (2014) BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability. Cancer Research, 74(10), pp. 2773-2784.
Sommers, C.L., Heckford, S.E., Skerker, J.M., Worland, P., Torri, J.A., Thompson, E.W., et al. (1992) Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Research, 52(19), pp. 5190-5197.
Tester, A.M., Waltham, M., Oh, S.J., Bae, S.N., Bills, M.M., Walker, E.C., et al. (2004) Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice. Cancer Research, 64(2), pp. 652-658.
Thompson, E.W., Katz, D., Shima, T.B., Wakeling, A.E., Lippman, M.E., & Dickson, R.B. (1989) ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Research, 49(24(I)), pp. 6929-6934.
Thompson, E.W., Nakamura, S., Shima, T.B., Melchiori, A., Martin, G.R., Salahuddin, S.Z., et al. (1991) Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Research, 51(10), pp. 2670-2676.
Thompson, E.W., Reich, R., Shima, T.B., Albini, A., Graf, J., Martin, G.R., et al. (1988) Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Research, 48(23), pp. 6764-6768.
Thompson, Erik W. & Newgreen, Donald F. (2005) Carcinoma invasion and metastasis : a role for epithelial-mesenchymal transition? Cancer Research, 65(14), pp. 5991-5995.
Udabage, Lishanthi, Brownlee, Garry R., Waltham, Mark, Blick, Tony, Walker, Emma C., Heldin, Paraskevi, et al. (2005) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Research, 65(14), pp. 6139-6150.
Ulrich, T.A., de Juan Pardo, E.M., & Kumar, S. (2009) The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Research, 69(10), pp. 4167-4174.
Wang, Qian, Bailey, Charles, Ng, Cynthia, Tiffen, Jessamy, Thoeng, Annora, Minhas, Vineet, et al. (2011) Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Research, 71(24), pp. 7525-7536.
Yu, Ming, Bowden, Emma T., Sitlani, Jay, Sato, Hiroshi, Seiki, Motoharu, Mueller, Susette C., et al. (1997) Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells. Cancer Research, 57(22), pp. 5028-5032.
Yu, Ming, Sato, Hiroshi, Seiki, Motoharu, & Thompson, Erik W. (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Research, 55(15), pp. 3272-3277.
Yuan, Xianglian, Yu, Liang, Li, Junhua, Xie, Guohua, Rong, Tingting, Zhang, Liang, et al. (2013) ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Cancer Research, 73(12), pp. 3625-3637.
Zavadil, Jiri, Haley, John, Kalluri, Raghu, Muthuswamy, Senthil K., & Thompson, Erik W. (2008) Epithelial-mesenchymal transition. Cancer Research, 68(23), pp. 9574-9577.
Zijlstra, Andries, Mellor, Rebecca, Panzarella, Giano, Aimes, Ronald T., Hooper, John D., Marchenko, Natalia D., et al. (2002) A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Research, 62(23), pp. 7083-7092.
Zoubeidi, Amina, Zardan, Anousheh, Beraldi, Eliana, Fazli, Ladan, Sowery, Richard, Rennie, Paul, et al. (2007) Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Cancer Research, 67(21), pp. 10455-10465.
de Keizer, Peter L.J., Packer, Leisl M., Szypowska, Anna A., Riedl-Polderman, Paulien E., van den Broek, Niel J.F., de Bruin, Alain, et al. (2010) Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. Cancer Research, 70(21), pp. 8526-8536.